STUDY TITLE: Phase 1b Trial of Ex-Vivo Fucosylated TGFBDNRII-CRC-TILS for the Treatment of Colorectal Cancer Patients with Minimal Residual Disease or Borderline Resectable Metastatic Disease
Key Eligibility Criteria
Drug:
See ClinicalTrials.gov for more details:
Study Record